Bilirubin increases the viability of osteoclasts and up-regulates osteoclast-related microRNAs
Susana Jurado+5 more
doaj
Primary Sjögren's syndrome manifesting as sclerotic metabolic bone disease. [PDF]
Boro H, Goyal A, Naik SS, Tandon N.
europepmc +1 more source
Metabolic features of myeloma cells in the context of bone microenvironment: Implication for the pathophysiology and clinic of myeloma bone disease [PDF]
Vincenzo Raimondi+5 more
openalex +1 more source
Progress of Immune‐Inducible Biomaterials for Post‐Ablation Cancers
The presence of residual tumors after ablative therapies poses a significant challenge, generally resulting in recurrence and metastases. This review offers a concise overview of immune‐inducible biomaterials from the perspective of the cancer‐immunity cycle, and how they enhance antitumor immunity through diverse mechanisms following ablative ...
Shuangshuang Zhao+7 more
wiley +1 more source
Early calcium and phosphorus supplementation in VLBW infants to reduce metabolic bone disease of prematurity: a quality improvement initiative. [PDF]
Krithika MV+5 more
europepmc +1 more source
Dietary Bioactives: Their Role in the Prevention and Treatment of Cardiovascular and Metabolic Bone Diseases [PDF]
Domitilla Mandatori, Assunta Pandolfi
openalex +1 more source
Cell Surface Thiol Engineering Mechanoregulates Myogenic Differentiation via the FAK–PI3K–AKT Axis
Schematic diagram illustrating how cell surface modification of skeletal muscle progenitor cells through TCEP treatment reveals enhanced cell adhesion, intracellular tension, and myogenesis at 19.66 kPa stiffness, leading to optimal cell fusion. In contrast, no significant changes are observed in the softer (10.61 kPa) or stiffer (49.4 kPa) matrices ...
Juyeon Kim+10 more
wiley +1 more source
The Chinese Metabolic Management Centers
Jianmin Liu, Zachary Bloomgarden
doaj +1 more source